Cargando…

Thyroid eye disease: From pathogenesis to targeted therapies

Thyroid eye disease (TED) is the most common extrathyroidal manifestation of autoimmune Graves’ hyperthyroidism. TED is a debilitating and potentially blinding disease with unclear pathogenesis. Autoreactive inflammatory reactions targeting orbital fibroblasts (OFs) lead to the expansion of orbital...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Jin Sook, Kikkawa, Don O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988977/ https://www.ncbi.nlm.nih.gov/pubmed/35399971 http://dx.doi.org/10.4103/tjo.tjo_51_21

Ejemplares similares

A bright new outlook on thyroid eye disease
por: Kikkawa, Don O.
Publicado: (2022)

Thyroid eye disease reactivation associated with COVID-19 vaccination
por: Park, Kathryn S., et al.
Publicado: (2022)

Early experience with teprotumumab for chronic thyroid eye disease
por: Ozzello, Daniel J., et al.
Publicado: (2020)

The Role of the Immune Response in the Pathogenesis of Thyroid Eye Disease: A Reassessment
por: Rosenbaum, James T., et al.
Publicado: (2015)

Change of intraocular blood flow during treatment for thyroid eye disease
por: Mimura, Masashi, et al.
Publicado: (2022)

Association of fibroblast growth factor 10 with the fibrotic and inflammatory pathogenesis of Graves’ orbitopathy
por: Jang, Sun Young, et al.
Publicado: (2021)

Molecular Pathogenesis and Targeted Therapies in Well-Differentiated Thyroid Carcinoma
por: Kim, Jung Guk
Publicado: (2014)

Understanding Pathogenesis Intersects With Effective Treatment for Thyroid Eye Disease
por: Smith, Terry J
Publicado: (2022)

The Role of Adipsin, Complement Factor D, in the Pathogenesis of Graves’ Orbitopathy
por: Byeon, Hyeong Ju, et al.
Publicado: (2023)

Longitudinal association of thyroid-stimulating immunoglobulin levels with clinical characteristics in thyroid eye disease
por: Ko, JaeSang, et al.
Publicado: (2022)

Thyroid Eye Disease
por: Rashad, Ramy, et al.
Publicado: (2022)

Correction to “Understanding Pathogenesis Intersects With Effective Treatment for Thyroid Eye Disease”
Publicado: (2022)

An overview of thyroid eye disease
por: McAlinden, Colm
Publicado: (2014)

The Pathogenesis of Staphylococcus aureus Eye Infections
por: O’Callaghan, Richard J.
Publicado: (2018)

Transcriptome Analysis of Orbital Adipose Tissue in Active Thyroid Eye Disease Using Next Generation RNA Sequencing Technology
por: Lee, Bradford W., et al.
Publicado: (2018)

Update on thyroid eye disease and management
por: Bothun, Erick D, et al.
Publicado: (2009)

Potential Therapeutic Role of Bone Morphogenic Protein 7 (BMP7) in the Pathogenesis of Graves’ Orbitopathy
por: Kim, Bo Yi, et al.
Publicado: (2022)

Crouzon syndrome and the eye: An overview
por: Bhattacharjee, Kasturi, et al.
Publicado: (2022)

Orbital Decompression in Thyroid Eye Disease
por: Fichter, N., et al.
Publicado: (2012)

Construction of the coexpression network involved in the pathogenesis of thyroid eye disease via bioinformatics analysis
por: Hu, Jinxing, et al.
Publicado: (2022)

An update on the pathogenesis of Hashimoto’s thyroiditis
por: Weetman, A. P.
Publicado: (2020)

Efficacy and Safety of Teprotumumab in Thyroid Eye Disease
por: Teo, Honeylen Maryl, et al.
Publicado: (2021)

Updates on the understanding and management of thyroid eye disease
por: Men, Clara J., et al.
Publicado: (2021)

Thyroid Eye Disease: How A Novel Therapy May Change The Treatment Paradigm
por: Wang, Yao, et al.
Publicado: (2019)

Psoriatic Arthritis: Pathogenesis and Targeted Therapies
por: Azuaga, Ana Belén, et al.
Publicado: (2023)

Management of Thyroid Eye Disease-Related Strabismus
por: Akbari, Mohammad Reza, et al.
Publicado: (2020)

Protein tyrosine phosphatase 1B as a therapeutic target for Graves’ orbitopathy in an in vitro model
por: Byeon, Hyeong Ju, et al.
Publicado: (2020)

Glycogen Synthase Kinase-3β Mediates Proinflammatory Cytokine Secretion and Adipogenesis in Orbital Fibroblasts from Patients with Graves’ Orbitopathy
por: Lee, Jihei Sara, et al.
Publicado: (2020)

Thyroid eye disease /
por: Char, Devron H., 1945-
Publicado: (1990)

Basal Cell Carcinoma: From the Molecular Understanding of the Pathogenesis to Targeted Therapy of Progressive Disease
por: Göppner, Daniela, et al.
Publicado: (2011)

Therapeutic Potential of Targeting Periostin in the Treatment of Graves’ Orbitopathy
por: Jang, Sun Young, et al.
Publicado: (2022)

Clinical Relevance of Environmental Factors in the Pathogenesis of Autoimmune Thyroid Disease
por: Wiersinga, Wilmar M.
Publicado: (2016)

Prognostic factors of restrictive myopathy in thyroid eye disease
por: Choi, Jae Hwan, et al.
Publicado: (2021)

Metallothioneins in Inflammatory Bowel Diseases: Importance in Pathogenesis and Potential Therapy Target
por: Socha-Banasiak, Anna, et al.
Publicado: (2021)

Management of eyelid retraction related to thyroid eye disease
por: Osaki, Tammy H., et al.
Publicado: (2022)

Molecular Targets in Alzheimer's Disease: From Pathogenesis to Therapeutics
por: Cheng, Xuan, et al.
Publicado: (2015)

Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases
por: Xia, Xiaohuan, et al.
Publicado: (2022)

The microbiome in inflammatory bowel diseases: from pathogenesis to therapy
por: Liu, Sheng, et al.
Publicado: (2020)

Therapeutic effect of ibrutinib, a selective Bruton’s tyrosine kinase inhibitor, in orbital fibroblasts from patients with Graves’ orbitopathy
por: Park, Hyun Young, et al.
Publicado: (2022)

Impact of iodine intake on the pathogenesis of autoimmune thyroid disease in children and adults
por: Kalarani, Iyshwarya Bhaskar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9purhrssvrn4398ti1v0t35n48